Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial

IMPORTANCE: Whether culture expanded mesenchymal stem cells or whole bone marrow mononuclear cells are safe and effective in chronic ischemic cardiomyopathy (ICM) remains controversial. OBJECTIVE: To demonstrate the safety of transendocardial stem cell injection with autologous mesenchymal stem cell...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Heldman, Alan W., DiFede, Darcy L., Fishman, Joel E, Zambrano, Juan P., Trachtenberg, Barry H., Karantalis, Vasileios, Mushtaq, Muzammil, Williams, Adam R., Suncion, Viky Y., McNiece, Ian K., Ghersin, Eduard, Soto, Victor, Lopera, Gustavo, Miki, Roberto, Willens, Howard, Hendel, Robert, Mitrani, Raul, Pattany, Pradip, Feigenbaum, Gary, Oskouei, Behzad, Byrnes, John, Lowery, Maureen H., Sierra, Julio, Pujol, Mariesty V, Delgado, Cindy, Gonzalez, Phillip J., Rodriguez, Jose E., Bagno, Luiza Lima, Rouy, Didier, Altman, Peter, Foo, Cheryl Wong Po, da Silva, Jose, Anderson, Erica, Schwarz, Richard, Mendizabal, Adam, Hare, Joshua M.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111133/
https://ncbi.nlm.nih.gov/pubmed/24247587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2013.282909
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires